Previous close | 19.56 |
Open | 19.80 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 19.56 - 19.56 |
52-week range | 16.76 - 24.84 |
Volume | |
Avg. volume | 552 |
Market cap | 5.577B |
Beta (5Y monthly) | 0.58 |
PE ratio (TTM) | 23.29 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.42 (2.16%) |
Ex-dividend date | 23 Apr 2024 |
1y target est | N/A |
STOCKHOLM (Reuters) -Swedish medical equipment maker Getinge reported on Thursday a smaller than expected rise in fourth-quarter earnings as costs squeezed margins and its organic order intake fell, sending its shares down. Operating profit was 1.14 billion crowns ($109 million) against a year-ago 828 million and a mean forecast of 1.36 billion in an LSEG poll of analysts, on organic sales growth of 10%. Getinge said this was mainly due to a tough year-ago comparison in connection with China lifting pandemic restrictions.
European shares edged lower on Monday as rising government bond yields and concerns over the Israel-Hamas war kept investors on edge, while Italy's FTSE MIB index was among top gainers across the regional markets. The pan-European STOXX 600 ended 0.1% lower after declines of over 3% in the previous week. While European Union leaders are set to call for a "humanitarian pause" in the Israel-Hamas war so aid could reach them, Israel continued its bombardment of the besieged enclave.
Medical equipment maker Getinge on Tuesday reported a sharp drop in second-quarter core profit, hit by quality and supply chain problems in its Cardiac Assist and Cardiopulmonary product categories. The Swedish group had warned in June that the problems would have a negative impact of around 400 million Swedish crowns ($39.19 million) on quarterly profit. Chief Executive Mattias Perjos in June said the majority of the profit hit would be due to scrapped inventory related to product and packaging issues.